Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
22.67
-0.12 (-0.50%)
Nov 5, 2024, 1:19 PM EST - Market open

Genmab Stock Forecast

Stock Price Forecast

The 6 analysts with 12-month price forecasts for Genmab stock have an average target of 43, with a low estimate of 31 and a high estimate of 50. The average target predicts an increase of 89.72% from the current stock price of 22.67.

Analyst Consensus: Buy
Target Low Average Median High
Price $31 $43 $48 $50
Change +36.77% +89.72% +111.78% +120.60%

Analyst Ratings

The average analyst rating for Genmab stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating May '24Jun '24Jul '24Aug '24Sep '24Oct '24
Strong Buy 333333
Buy 112222
Hold 000122
Sell 111111
Strong Sell 000000
Total 556788

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$50
Strong Buy Reiterates $50 +120.60% Oct 16, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$50
Strong Buy Reiterates $50 +120.60% Sep 20, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$50
Strong Buy Reiterates $50 +120.60% Sep 16, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$50
Strong Buy Reiterates $50 +120.60% Sep 13, 2024
Morgan Stanley
Morgan Stanley
Hold
Maintains
$31
Hold Maintains $31 +36.77% Sep 11, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
21.47B
from 16.47B
Increased by 30.31%
Revenue Next Year
25.01B
from 21.47B
Increased by 16.49%
EPS This Year
86.24
from 66.02
Increased by 30.63%
EPS Next Year
98.92
from 86.24
Increased by 14.70%
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
5.37B10.11B8.42B14.51B16.47B21.47B25.01B28.78B
Revenue Growth
77.39%88.43%-16.75%72.33%13.57%30.31%16.49%15.09%
EPS
34.0372.2144.7782.5966.0286.2498.92124.57
EPS Growth
43.40%112.20%-38.00%84.48%-20.06%30.63%14.70%25.93%
Forward PE
-----1.801.571.24
No. Analysts -----272722
Financial currency is DKK. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 23.0B 28.2B 32.5B
Avg 21.5B 25.0B 28.8B
Low 19.6B 21.0B 24.1B

Revenue Growth

Revenue Growth 20242025202620272028
High
39.5%
31.4%
30.1%
Avg
30.3%
16.5%
15.1%
Low
18.9%
-2.3%
-3.6%

EPS Forecast

EPS 20242025202620272028
High 98.10 141.03 187.12
Avg 86.24 98.92 124.57
Low 75.14 71.58 86.54

EPS Growth

EPS Growth 20242025202620272028
High
48.6%
63.5%
89.2%
Avg
30.6%
14.7%
25.9%
Low
13.8%
-17.0%
-12.5%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.